A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma

Satoru Yokoyama(Harvard University), Susan L. Woods(QIMR Berghofer Medical Research Institute), Glen M. Boyle(QIMR Berghofer Medical Research Institute), Lauren G. Aoude(QIMR Berghofer Medical Research Institute), Stuart MacGregor(QIMR Berghofer Medical Research Institute), Victoria Zismann(Translational Genomics Research Institute), Michael G. Gartside(QIMR Berghofer Medical Research Institute), Anne Ε. Cust(The University of Sydney), Rizwan Haq(Harvard University), Mark Harland(Cancer Research UK), John Taylor(Cancer Research UK), David L. Duffy(QIMR Berghofer Medical Research Institute), Kelly Nudelman(QIMR Berghofer Medical Research Institute), Ken Dutton‐Regester(QIMR Berghofer Medical Research Institute), Jane M. Palmer(QIMR Berghofer Medical Research Institute), Vanessa Bonazzi(QIMR Berghofer Medical Research Institute), Mitchell Stark(QIMR Berghofer Medical Research Institute), Judith Symmons(QIMR Berghofer Medical Research Institute), Matthew H. Law(QIMR Berghofer Medical Research Institute), Christopher Schmidt(QIMR Berghofer Medical Research Institute), Cathy Lanagan(QIMR Berghofer Medical Research Institute), Linda O’Connor(QIMR Berghofer Medical Research Institute), Elizabeth A. Holland(The University of Sydney), Helen Schmid(The University of Sydney), Judith A Maskiell(The University of Melbourne), Jodie Jetann(Cancer Council Queensland), Megan Ferguson(Cancer Council Queensland), Mark A. Jenkins(The University of Melbourne), Richard Kefford(The University of Sydney), Graham G. Giles(Cancer Council Victoria), Bruce K. Armstrong(The University of Sydney), Joanne F. Aitken(Cancer Council Queensland), John L. Hopper(The University of Melbourne), David C. Whiteman(QIMR Berghofer Medical Research Institute), Paul D.P. Pharoah(University of Cambridge), Douglas F. Easton(University of Cambridge), Alison M. Dunning(University of Cambridge), Julia Newton‐Bishop(Cancer Research UK), Grant W. Montgomery(QIMR Berghofer Medical Research Institute), Nicholas G. Martin(QIMR Berghofer Medical Research Institute), Graham J. Mann(The University of Sydney), D. Timothy Bishop(Cancer Research UK), Hensin Tsao(Harvard University), Jeffrey M. Trent(Translational Genomics Research Institute), David E. Fisher(Harvard University), Nicholas K. Hayward(QIMR Berghofer Medical Research Institute), Kevin M. Brown(Translational Genomics Research Institute)
Nature
November 11, 2011
Cited by 472Open Access
Full Text

Abstract

Whole-genome sequencing identifies a novel germline variant in the oncogene MITF, which is associated with the development of melanoma. Two papers in this issue of Nature demonstrate that missense substitutions in the gene encoding for microphthalmia-associated transcription factor (MITF) are associated with susceptibility to melanoma and renal cell carcinoma. Functional analysis shows that the variant has impaired sumoylation that leads to differential regulation of several MITF targets, and promotes tumour cell clonogenicity, migration and invasion. So far, two genes associated with familial melanoma have been identified, accounting for a minority of genetic risk in families. Mutations in CDKN2A account for approximately 40% of familial cases1, and predisposing mutations in CDK4 have been reported in a very small number of melanoma kindreds2. Here we report the whole-genome sequencing of probands from several melanoma families, which we performed in order to identify other genes associated with familial melanoma. We identify one individual carrying a novel germline variant (coding DNA sequence c.G1075A; protein sequence p.E318K; rs149617956) in the melanoma-lineage-specific oncogene microphthalmia-associated transcription factor (MITF). Although the variant co-segregated with melanoma in some but not all cases in the family, linkage analysis of 31 families subsequently identified to carry the variant generated a log of odds (lod) score of 2.7 under a dominant model, indicating E318K as a possible intermediate risk variant. Consistent with this, the E318K variant was significantly associated with melanoma in a large Australian case–control sample. Likewise, it was similarly associated in an independent case–control sample from the United Kingdom. In the Australian sample, the variant allele was significantly over-represented in cases with a family history of melanoma, multiple primary melanomas, or both. The variant allele was also associated with increased naevus count and non-blue eye colour. Functional analysis of E318K showed that MITF encoded by the variant allele had impaired sumoylation and differentially regulated several MITF targets. These data indicate that MITF is a melanoma-predisposition gene and highlight the utility of whole-genome sequencing to identify novel rare variants associated with disease susceptibility.


Related Papers

No related papers found

Powered by citation graph analysis